GNS Healthcare

OverviewSuggest Edit

GNS Healthcare is a healthcare analytics company, founded in 2000 and based in Kendall Square, Cambridge, MA. They focus on advancing and applying industrial-scale data analytics to empower key healthcare stakeholders to solve complex care, treatment and cost challenges. They are a multi-disciplinary group of physicists, actuaries, geneticists, engineers, business people, and computer scientists, passionate about extracting the evidence of what works in healthcare and for whom.
TypePrivate
Founded2000
HQCambridge, US
Websitegnshealthcare.com
Employee Ratings2.8

Latest Updates

Employees (est.) (May 2020)94

Key People/Management at GNS Healthcare

Colin Hill

Colin Hill

Chairman, CEO and Co-Founder
Iya Khalil

Iya Khalil

Chief Commercial Officer and Co-Founder
Jan Berger

Jan Berger

Director
Bruce Church

Bruce Church

Chief Mathematics Officer
David Gascoigne

David Gascoigne

Chief Operating Officer
Rob Coppedge

Rob Coppedge

Director
Show more

GNS Healthcare Office Locations

GNS Healthcare has offices in Cambridge and Austin
Cambridge, US (HQ)
196 Broadway
Cambridge, US (HQ)
196 Broadway
Austin, US
701 Brazos St
Show all (3)

GNS Healthcare Financials and Metrics

Summary Metrics

Founding Date

2000

GNS Healthcare total Funding

$72.1 m

GNS Healthcare latest funding size

$23 m

Time since last funding

a year ago

GNS Healthcare investors

GNS Healthcare's latest funding round in July 2019 was reported to be $23 m. In total, GNS Healthcare has raised $72.1 m
Show all financial metrics

GNS Healthcare Online and Social Media Presence

Embed Graph

GNS Healthcare Company Culture

  • CEO Rating

    F

    30/100

  • Compensation

    F

    10/100

Learn more on Comparably

GNS Healthcare News and Updates

GNS Healthcare inks $23 mln Series D

Cambridge, Massachusetts-based GNS Healthcare, a precision medicine company, has raised $23 million in Series D funding round. Cigna Ventures led the round.

GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology

CAMBRIDGE, Mass., July 2, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), is presenting discoveries of predictive biomarkers for metastatic colorectal cancer (mCRC) patient response to...

Business Health Care Group of Wisconsin Partners with GNS Healthcare to Improve Value of Care Across State

MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- The Business Health Care Group (BHCG), a coalition of employers located in Wisconsin covering 200,000 lives, has partnered with GNS Healthcare (GNS), a leading precision medicine company, to discover best practices of health...

GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018

CAMBRIDGE, Mass., Oct. 22, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic colorectal cancer this week from their most recent collaboration with the Alliance for Clinical Trials in Oncology (Alliance) at the ESMO 2018...

GNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine's List of Top Female Founders for 2018

CAMBRIDGE, Mass., Oct. 5, 2018 /PRNewswire/ -- Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was profiled as one...

GNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer

CAMBRIDGE, Mass., Oct. 3, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in the...
Show more

GNS Healthcare Blogs

ASCO-SITC: Causal Modeling of TCGA NSCLC and HNSCC Data Identifies Network Drivers of Tumor Immune Subtypes

https://info.gnshealthcare.com/asco-tcga The post ASCO-SITC: Causal Modeling of TCGA NSCLC and HNSCC Data Identifies Network Drivers of Tumor Immune Subtypes appeared first on GNS.

Colin Hill to Speak at MassBio’s State of Possible Conference

This year’s State of Possible Conference, MassBio’s Annual Meeting, will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facin…

Iya Khalil to Weigh in on How AI is Transforming Early-Stage Biotech Partnerships and Drug Discovery

Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming industries, from autonomous cars, to logistics, to technology – and now biotechnology. Excitement about AI and ML driven solutions for accelerated drug discovery, drug development, and drug data analysis, among others, i…

GNS Co-founders to speak at Elsevier’s first AI and Big Data in Cancer Conference

The future of medicine is data-driven and AI-enabled. Artificial intelligence will impact diagnosis, treatment decisions and patient care. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into clinical practices and patient …

Cambia’s Peggy Maguire: Palliative Care Supports Economic Sustainability

Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia’s Medicare Advantage population that could benefit from an extra layer of support. Read the full article here. The post Cambia’s Peggy Maguire: Palliativ…

GNS Healthcare Announces Strategic Investment from Merck Global Health Innovation Fund

Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. – January 7, 2020 – GNS Healthcar…
Show more

GNS Healthcare Frequently Asked Questions

  • When was GNS Healthcare founded?

    GNS Healthcare was founded in 2000.

  • Who are GNS Healthcare key executives?

    GNS Healthcare's key executives are Colin Hill, Iya Khalil and Jan Berger.

  • How many employees does GNS Healthcare have?

    GNS Healthcare has 94 employees.

  • Who are GNS Healthcare competitors?

    Competitors of GNS Healthcare include PeraHealth, Patagonia Health and EpiBone.

  • Where is GNS Healthcare headquarters?

    GNS Healthcare headquarters is located at 196 Broadway, Cambridge.

  • Where are GNS Healthcare offices?

    GNS Healthcare has offices in Cambridge and Austin.

  • How many offices does GNS Healthcare have?

    GNS Healthcare has 3 offices.